Lotus Eye Hospital and Institute Ltd. - LOTUSEYE, 532998 corporate action history

Lotus Eye Hospital and Institute Ltd. NSE: LOTUSEYE | BSE: 532998

Expensive Rocket

Download real time

126.18 -4.12 (-3.16%)

New 52W High in past week

106.5K

NSE+BSE Volume

NSE 04 Sep, 2025 3:31 PM (IST)

Lotus Eye Hospital and Institute Ltd. Bonus history

Lotus Eye Hospital and Institute Ltd. has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Lotus Eye Hospital and Institute Ltd. Split history

Lotus Eye Hospital and Institute Ltd. has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Lotus Eye Hospital and Institute Ltd.

Lotus Eye Hospital and Institute Ltd. has declared 5 dividends since Aug. 2, 2017.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
18 Sep 2023	0.50	FINAL	-	Equity Share
08 Sep 2022	0.50	FINAL	10 Sep 2022	Equity Share
08 Sep 2021	0.50	FINAL	-	Equity Share
14 Sep 2018	0.50	FINAL	-	Equity Share
02 Aug 2017	0.50	FINAL	-	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Lotus Eye Hospital and Institute Ltd.

The latest board meeting for Lotus Eye Hospital and Institute Ltd. took place on 12 Aug 2025, for the purpose of Quarterly Results

Ex-Date	Purpose	Notes
12 Aug 2025	Quarterly Results	-
29 May 2025	Audited Results	-
12 Feb 2025	Quarterly Results	-
12 Nov 2024	Quarterly Results	-
14 Aug 2023	Quarterly Results	-
24 May 2023	Audited Results & Dividend	-
13 Feb 2023	Quarterly Results	-
14 Nov 2022	Audited Results	-
09 Aug 2022	Quarterly Results	-
25 May 2022	Audited Results & Final Dividend	-

See all Board Meetings for Lotus Eye Hospital and Institute Ltd.

Lotus Eye Hospital and Institute Ltd. Rights history

Lotus Eye Hospital and Institute Ltd. has not issued any rights since Jan 1, 2000.

See all Rights History for Lotus Eye Hospital and Institute Ltd.

Is Lotus Eye Hospital and Institute Ltd. worth buying?

29 Votes:

Buy 68.97%

Sell 13.79%

Hold 17.24%